Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-11-07

Clinical Trial Update: Meal Timing on Postprandial Glucose, Insulin and GLP-1 in Type 2 Diabetes [NA]

View source ↗

Summary

A clinical trial update from Tel Aviv University examining how meal timing influences postprandial glucose, insulin, and GLP-1 levels in individuals with Type 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tel Aviv University | Conditions: Type 2 Diabetes | NA | Status: UNKNOWN